SDC1 and Miyoshi myopathy: The very high proliferation and short doubling time of HMCLs compared to most primary CD138+ malignant plasma cells from MM patients is likely one explanation for this difference as HMCLs are typically reflective of disease biology that is most aggressive and derived from MM patients at the end stages of their disease.